GT Biopharma, Inc.
Current role
GTBP
Biotechnology · Healthcare
CFO, Board Member
2022-06-09–present
Alan L. Urban
Board Member
GT Biopharma, Inc. (GTBP)Equibles does not estimate personal net worth.
Get an email with a short summary when GT Biopharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get GTBP alertsAbout Alan L. Urban
Alan L. Urban is recorded as CFO at GT Biopharma, Inc. (GTBP) since June 3, 2024 and Board Member at GT Biopharma, Inc. (GTBP) since June 9, 2022. GT Biopharma, Inc. reported in an 8-K filed June 7, 2024 that Alan L. Urban was appointed Chief Financial Officer, effective June 3, 2024. GT Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at GT Biopharma, Inc. includes Anthony Cataldo (CEO), Dr. Gregory Berk (CEO), Michael Breen (CEO and Board Member) and 7 others.
“on June 3, 2024, the Company has appointed Alan L. Urban as the Company's Chief Financial Officer.”
Affiliation history
-
Current
2024-06-03–present
-
Current
2022-06-09–present
Company network
Leadership on record at GT Biopharma, Inc.
- Anthony Cataldo CEO
- Dr. Gregory Berk CEO
- Michael Breen CEO, Board Member
- Bruce Wendel Chairman
- Alan Urban CFO
- Dr. Gavin Choy CFO
- Michael Handelman CFO
- Andrew Ritter Board Member
- Charles J. Casamento Board Member
- David C. Mun-Gavin Board Member